
FATE THERAPEUTICS, I
FATE
![]() |
|
89.72USD | +4.00% |
Upcoming events on FATE THERAPEUTICS, INC.
05/12/21 | Q1 2021 Earnings Release (Projected) |
08/09/21 | Interim 2021 Earnings Release (Projected) |
11/10/21 | Q3 2021 Earnings Release (Projected) |
03/07/22 | FY 2021 Earnings Release (Projected) |
Past events on FATE THERAPEUTICS, INC.
02/24/21 | 05:00pm | FY 2020 Earnings Call |
02/24/21 | FY 2020 Earnings Release |
12/05/20 | American Society of Hematology Meeting |
12/04/20 | 04:30pm | Business Update Call |
Upcoming sector events for FATE THERAPEUTICS, INC.
02/26/21 | 04:35pm | REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 010 |
02/26/21 | REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 290 |
02/26/21 | REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 447 |
02/26/21 | REGENERON PHARMACEUTICALS, INC. : American Academy of Allergy, Asthma and Immunology Virtual Meeting - Poster 425 |
Past sector events for FATE THERAPEUTICS, INC.
02/25/21 | 01:40pm | GILEAD SCIENCES, INC. : SVB Leerink Global Healthcare Conference |
02/25/21 | 01:40pm | EXACT SCIENCES CORPORATION : SVB Leerink Global Healthcare Conference |
02/25/21 | IOVANCE BIOTHERAPEUTICS, INC. : FY 2020 Earnings Release |
02/25/21 | VIR BIOTECHNOLOGY, INC. : FY 2020 Earnings Release |
Annual results
![]() | Next Year |
Annual results | 2020 | 2021 (e) | |
Sales M $ |
Released Forecast Spread | 31,4 21,2 48% | 26,2 |
Operating income (EBITDA) M $ |
Released Forecast Spread | -128 -130 1,3% | -177 |
Operating profit (EBIT) M $ |
Released Forecast Spread | -173 -148 -17% | -171 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -173 -149 -17% | -169 |
Net income $ |
Released Forecast Spread | -2,10 -1,84 -14% | -1,81 |
Announcement Date | 02/24/2021 |
Quarterly / Semiannualy publications
![]() | Next period![]() |
Quarterly results | 2020 Q4 | 2021 Q1 (e) | |
Sales M $ |
Released Forecast Spread | 15,9 5,64 182% | 6,49 |
Operating income (EBITDA) M $ |
Released Forecast Spread | -33,4 -35,1 4,7% | -41,0 |
Operating profit (EBIT) M $ |
Released Forecast Spread | -53,1 -35,2 -51% | -40,4 |
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -53,1 -35,4 -50% | -39,3 |
Net income $ |
Released Forecast Spread | -0,61 -0,41 -50% | -0,43 |
Announcement Date | 02/24/2021 |
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise